KVUE - NYSE
Kenvue Inc.
$16.83
-3.0%Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
At a Glance
Live SnapshotKenvue Inc. Management Team
Ms. Heather R. Howlett
Chief Accounting Officer
Mr. Bernardo Tavares
Chief Data & Technology Officer
Mr. Kirk L. Perry
Chief Executive Officer & Director
Compensation
$7,967
Mr. Thibaut Mongon
Chief Executive Officer & Director
Compensation
$4,203,218
Mr. Amit Banati
Chief Financial Officer
Ms. Meredith Stevens
Chief Operations Officer
Compensation
$1,829,114
Ms. Luani Alvarado
Chief People Officer
Dr. Caroline Tillett Ph.D.
Chief Scientific Officer
Mr. Michael Wondrasch
Chief Technology & Data Officer
Mr. Matthew Orlando
General Counsel
Ms. Ellie Bing Xie
Group President of Asia Pacific
Compensation
$2,633,875
Mr. Carlton Lawson
Group President of EMEA & Latin America
Compensation
$2,300,258
Kenvue Inc. Insider Positioning
During the last 12 months, insiders have purchased $110.99M and sold $680K worth of KVUE shares, resulting in $110.31M of net buying activity.
3 Months
0
0.00
38.5K
679.68K
-680K
-$680K
3-6 Months
6.4M
110.99M
0
0.00
+111.0M
+$110.99M
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
Smith Jeffrey C
Director
$110.99M
Top Sellers
Orlando Matthew
Officer: General Counsel
$680K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $110.31M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.
SEC Filings
KVUE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | April 08, 2026 | December 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 09, 2025 | December 29, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 10, 2024 | December 31, 2023 | 2023 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.